Harbin Medisan Pharmaceutical Co.,Ltd.’s Net Profit Dropped 96.8% in First Half of 2022

Harbin Medisan Pharmaceutical Co.,Ltd. (哈尔滨三联药业股份有限公司) (002900.SZ) reported a net profit of 18.8 million yuan in the first half of 2022, down 96.8% year-on-year.

Meanwhile, the company posted 504.7 million yuan in revenue, up 6.5% year-on-year.

At the end of the reporting period, it had 3.2 billion yuan in total assets and 1.1 billion yuan in total liabilities, with a liability-to-asset ratio of 35.8%.